Trial intelligence / Profile preview

Mechanism of Interaction Between Salvianolate and Aspirin in Stable Angina

NCT03306550Unknown

Sponsor
Xiyuan Hospital
Start
Oct 2017
Primary completion
Apr 2018
Modality
Small Molecules
01

Overview

Randomised, open-label trial of salvianolate in stable angina (3 arms), sponsored by Xiyuan Hospital. Primary endpoints: Change of P-selection expression on platelet activation-dependent granule membrane, Change of PAC-1 expression on activated platelets and 2 more. Status: unknown.

02

Drugs

salvianolate
03

Conditions

stable angina

Beyond the preview

Go deeper on NCT03306550.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03306550.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call